Beam Therapeutics Inc. announced it raised $45 Million in an initial filing
08/09/18, 7:58 PM
Location
Money raised
$45 million
Industry
therapeutics
biotechnology
health care
Company Info
Location
325 vassar street, suite 2a
cambridge, massachusetts, united states
Additional Info
Beam Therapeutics, launched in 2018, is pioneering the use of CRISPR base editing to develop a broad portfolio of advanced genetic medicines. Our groundbreaking base editing technology allows us to make permanent, specific edits to single bases in DNA and RNA, without cutting the strands. Base editor therapeutics represent a new class of “precision genetic medicines,” combining precision targeting of the genome with precision control of editing outcomes.